4.6 Article

Outcomes of Surgical Coronary Revascularization Performed Before Solid Abdominal Organ Transplants

期刊

ANNALS OF THORACIC SURGERY
卷 111, 期 2, 页码 568-575

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.athoracsur.2020.05.077

关键词

-

向作者/读者索取更多资源

Patients undergoing CABG to attain kidney or liver transplant candidacy had significantly higher major adverse postoperative outcomes compared to non-transplant patients, with higher rates of 30-day mortality and neurologic events. Most patients in the pretransplant group did not ultimately undergo organ transplantation, indicating the need for further research on postoperative management strategies in this high-risk population.
Background. Cardiac risk stratification and coronary angiography are routinely performed as part of kidney and liver transplant candidacy evaluation. There are limited data on the outcomes of surgical coronary revascularization in this patient population. This study investigated outcomes in patients with end-stage renal or hepatic disease who were undergoing coronary artery bypass grafting (CABG) to attain kidney or liver transplant candidacy. Methods. This study was a retrospective analysis of all patients who underwent isolated CABG at our institution, Indiana University School of Medicine (Indianapolis, IN), between 2010 and 2016. Patients were divided into 2 cohorts: pretransplant (those undergoing surgery to attain renal or hepatic transplant candidacy) and non-transplant (all others). Baseline characteristics and post-operative outcomes were compared between the groups. Results. A total of 1801 patients were included: 28 in the pretransplant group (n = 22, kidney; n = 7, liver) and 1773 in the nontransplant group. Major adverse postoperative outcomes were significantly greater in the pretransplant group compared with the nontransplant group: 30-day mortality (14.3% vs 2.8%; P = .009), neurologic events (17.9% vs 4.8%; P = .011), reintubation (21.4% vs 5.8%; P = .005), and total postoperative ventilation (5.2 hours vs 5.0 hours; P = .0124). The 1- and 5-year mortality in the pretransplant group was 17.9% and 53.6%, respectively. Of the pretransplant cohort, 3 patients (10.7%) underwent organ transplantation (all kidney) at a mean 436 days after CABG. No patients underwent liver transplantation. Conclusions. Outcomes after CABG in pre-kidney transplant and pre-liver transplant patients are poor. Despite surgical revascularization, most patients do not ultimately undergo organ transplantation. Revascularization strategies and optimal management in this high-risk population warrant further (C) 2021 by The Society of Thoracic Surgeons

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据